High_JJ
levels_NNS
of_IN
the_DT
DNA-binding_JJ
activity_NN
of_IN
E2F_NN
in_IN
adult_JJ
T-cell_NN
leukemia_NN
and_CC
human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
I-infected_JJ
cells_NNS
:_:
possible_JJ
enhancement_NN
of_IN
DNA-binding_NN
of_IN
E2F_NN
by_IN
the_DT
human_JJ
T-cell_NN
leukemia_NN
virus_NN
I_CD
transactivating_NN
protein_NN
,_,
Tax_NN
._.

Transcription_NN
factor_NN
E2F_NN
binds_VBZ
to_TO
cellular_JJ
promoters_NNS
of_IN
certain_JJ
growth_NN
-_:
and_CC
cell_NN
cycle-controlling_JJ
genes_NNS
and_CC
forms_VBZ
distinct_JJ
heteromeric_JJ
complexes_NNS
with_IN
other_JJ
nuclear_JJ
proteins_NNS
._.

It_PRP
has_VBZ
therefore_RB
been_VBN
proposed_VBN
that_IN
E2F_NN
is_VBZ
involved_VBN
in_IN
cellular_JJ
proliferation_NN
control_NN
._.

Human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
I_CD
-LRB-_-LRB-
HTLV-I_NN
-RRB-_-RRB-
is_VBZ
an_DT
etiological_JJ
agent_NN
of_IN
adult_JJ
T-cell_NN
leukemia_NN
-LRB-_-LRB-
ATL_NN
-RRB-_-RRB-
._.

We_PRP
show_VBP
here_RB
by_IN
mobility-shift_JJ
assay_NN
that_IN
E2F-containing_JJ
DNA-binding_JJ
complexes_NNS
were_VBD
detected_VBN
in_IN
HTLV-I-infected_JJ
T-cell_NN
lines_NNS
and_CC
leukemic_JJ
cells_NNS
obtained_VBN
from_IN
ATL_NN
patients_NNS
but_CC
not_RB
in_IN
an_DT
uninfected_JJ
T-cell_NN
line_NN
,_,
Jurkat_NN
,_,
and_CC
normal_JJ
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
._.

The_DT
Tax_NN
protein_NN
,_,
encoded_VBN
by_IN
HTLV-I_NN
,_,
is_VBZ
a_DT
potent_JJ
transcription_NN
activator_NN
of_IN
viral_JJ
and_CC
several_JJ
cellular_JJ
genes_NNS
._.

We_PRP
demonstrate_VBP
that_IN
expression_NN
of_IN
Tax_NN
can_MD
induce_VB
the_DT
E2F-containing_JJ
DNA-binding_JJ
complexes_NNS
in_IN
Jurkat_NN
T_NN
cells_NNS
._.

Thus_RB
,_,
Tax_NN
,_,
through_IN
enhancement_NN
of_IN
the_DT
DNA-binding_JJ
activity_NN
of_IN
E2F_NN
,_,
may_MD
be_VB
capable_JJ
of_IN
regulating_VBG
cellular_JJ
gene_NN
expression_NN
implicated_VBN
in_IN
the_DT
proliferation_NN
and_CC
transformation_NN
of_IN
T_NN
cells_NNS
in_IN
ATL_NN
._.

This_DT
activity_NN
may_MD
be_VB
relevant_JJ
to_TO
the_DT
mechanisms_NNS
whereby_WRB
HTLV-I_NN
which_WDT
does_VBZ
not_RB
contain_VB
oncogenes_NNS
induces_VBZ
neoplasia_NN
._.

